Chromosome conformation elucidates regulatory relationships in developing human brain

Nature

Volumn 538, Issue 7626, 2016, Pages 523-527

  Won, Hyejung ^a   De La Torre Ubieta, Luis ^a   Stein, Jason L ^a,e   Parikshak, Neelroop N ^a   Huang, Jerry ^a   Opland, Carli K ^a   Gandal, Michael J ^a   Sutton, Gavin J ^b   Hormozdiari, Farhad ^c   Lu, Daning ^a   Lee, Changhoon ^a   Eskin, Eleazar ^c,d   Voineagu, Irina ^b   Ernst, Jason ^c,d   Geschwind, Daniel H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c University of California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; CHROMATIN; FORKHEAD TRANSCRIPTION FACTOR; FOXG1 PROTEIN, HUMAN; NERVE PROTEIN;

ARTIFICIAL NEURAL NETWORK; BRAIN; CHROMOSOME; COGNITION; GENE EXPRESSION; GENOME;

ARTICLE; BRAIN; BRAIN DEVELOPMENT; BRAIN MAPPING; CHOLINERGIC SYSTEM; CHROMATIN; CHROMOSOME; COGNITION; CONFORMATION; FOXG1 GENE; GENE; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; GENOME; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; PRIORITY JOURNAL; REGULATORY MECHANISM; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; THREE DIMENSIONAL IMAGING; ANTIBODY SPECIFICITY; CHEMISTRY; EMBRYOLOGY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN CHROMOSOME; METABOLISM; NEURAL STEM CELL; PATHOLOGY; PROMOTER REGION; REPRODUCIBILITY;

BRAIN; CHROMATIN; CHROMOSOMES, HUMAN; COGNITION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEUROGENESIS; NUCLEIC ACID CONFORMATION; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 84993993658     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature19847     Document Type: Article

References (46)

1. Lieberman-Aiden, E. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289-293 (2009).
2. Jin, F. et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503, 290-294 (2013).
3. Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665-1680 (2014).
4. Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155, 1008-1021 (2013).
5. McCarthy, S. E. et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol. Psychiatry 19, 652-658 (2014).
6. De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014).
7. Geschwind, D. H. & Rakic, P. Cortical evolution: judge the brain by its cover. Neuron 80, 633-647 (2013).
8. Reilly, S. K. et al. Evolutionary changes in promoter and enhancer activity during human corticogenesis. Science 347, 1155-1159 (2015).
9. Imakaev, M. et al. Iterative correction of Hi-C data reveals hallmarks of chromosome organization. Nat. Methods 9, 999-1003 (2012).
10. Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 (2012).
11. Sanyal, A., Lajoie, B. R., Jain, G. & Dekker, J. The long-range interaction landscape of gene promoters. Nature 489, 109-113 (2012).
12. Mifsud, B. et al. Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nat. Genet. 47, 598-606 (2015).
13. Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
14. Cookson, W., Liang, L., Abecasis, G., Moffatt, M. & Lathrop, M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184-194 (2009).
15. Duggal, G., Wang, H. & Kingsford, C. Higher-order chromatin domains link eQTLs with the expression of far-away genes. Nucleic Acids Res. 42, 87-96 (2014).
16. Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418-1428 (2014).
17. Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187 (2010).
18. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
19. Florio, M. et al. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion. Science 347, 1465-1470 (2015).
20. Bond, J. et al. ASPM is a major determinant of cerebral cortical size. Nat. Genet. 32, 316-320 (2002).
21. Necsulea, A. et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 505, 635-640 (2014).
22. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
23. Gulsuner, S. et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154, 518-529 (2013).
24. Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B. & Eskin, E. Identifying causal variants at loci with multiple signals of association. Genetics 198, 497-508 (2014).
25. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
26. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199-209 (2015).
27. Jones, C. K., Byun, N. & Bubser, M. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology 37, 16-42 (2012).
28. Graham, V., Khudyakov, J., Ellis, P. & Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 39, 749-765 (2003).
29. Roussos, P. et al. A role for noncoding variation in schizophrenia. Cell Reports 9, 1417-1429 (2014).
30. Kortüm, F. et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J. Med. Genet. 48, 396-406 (2011).
31. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. http://dx.doi.org/10.1038/nn.4399 (2016).
32. Dixon, J. R. et al. Chromatin architecture reorganization during stem cell differentiation. Nature 518, 331-336 (2015).
33. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
34. Miller, J. A. et al. Transcriptional landscape of the prenatal human brain. Nature 508, 199-206 (2014).
35. Miller, J. A., Horvath, S. & Geschwind, D. H. Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc. Natl Acad. Sci. USA 107, 12698-12703 (2010).
36. Ernst, J. & Kellis, M. Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues. Nat. Biotechnol. 33, 364-376 (2015).
37. van de Leemput, J. et al. CORTECON: a temporal transcriptome analysis of in vitro human cerebral cortex development from human embryonic stem cells. Neuron 83, 51-68 (2014).
38. Yao, P. et al. Coexpression networks identify brain region-specific enhancer RNAs in the human brain. Nat. Neurosci. 18, 1168-1174 (2015).
39. Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature 507, 462-470 (2014).
40. Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, e17 (2005).
41. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
42. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228-1235 (2015).
43. Stein, J. L. et al. A quantitative framework to evaluate modeling of cortical development by neural stem cells. Neuron 83, 69-86 (2014).
44. Hansen, K. D., Irizarry, R. A. & Wu, Z. Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics 13, 204-216 (2012).
45. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).
46. Oldham, M. C., Langfelder, P. & Horvath, S. Network methods for describing sample relationships in genomic datasets: application to Huntington's disease. BMC Syst. Biol. 6, 63 (2012).